Factors pivotal for designing of nanoantimicrobials: an exposition

References

• Abed N, Couvreur P. 2014. Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. Int J Antimicrob Agents 43:485–496.
   PubMed Web of Science ®Google Scholar
• Aggarwal P, Uppal B, Ghosh R, Krishna Prakash S, Chakravarti A, Jha AK, Rajeshwari K. 2016. Multi drug resistance and Extended Spectrum Beta Lactamases in clinical isolates of Shigella: a study from New Delhi, India. Travel Med Infect Dis. 14:407–413.
   PubMed Web of Science ®Google Scholar
• Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K. 2013. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8:102.
   PubMed Web of Science ®Google Scholar
• Alhajlan M, Alhariri M, Omri A. 2013. Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors. Antimicrob Agents Chemother. 57:2694–2704.
   PubMed Web of Science ®Google Scholar
• Allaker RP, Memarzadeh K. 2014. Nanoparticles and the control of oral infections. Int J Antimicrob Agents. 43:95–104.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. 2004. Drug delivery systems: entering the mainstream. Science. 303:1818–1822.
   PubMed Web of Science ®Google Scholar
• Andrade F, Rafael D, Videira M, Ferreira D, Sosnik A, Sarmento B. 2013. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Adv Drug Deliv Rev. 65:1816–1827.
   PubMed Web of Science ®Google Scholar
• Aruguete DM, Kim B, Hochella MF, Ma Y, Cheng Y, Hoegh A, Liu J, Pruden A. 2013. Antimicrobial nanotechnology: its potential for the effective management of microbial drug resistance and implications for research needs in microbial nanotoxicology. Env Sci Process Impact. 15:93–102.
   PubMed Web of Science ®Google Scholar
• Bald D, Koul A. 2013. Advances and strategies in discovery of new antibacterials for combating metabolically resting bacteria. Drug Discov Today. 18:250–255.
   PubMed Web of Science ®Google Scholar
• Bartosz G. 2009. Reactive oxygen species: destroyers or messengers? Biochem Pharmacol. 77:1303–1315.
   PubMed Web of Science ®Google Scholar
• Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJV. 2015. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 13:42–51.
   PubMed Web of Science ®Google Scholar
• Blaskovich MA, Zuegg J, Elliott AG, Cooper MA. 2015. Helping chemists discover new antibiotics. ACS Infect Dis. 1:285–287.
   PubMed Web of Science ®Google Scholar
• Blecher K, Nasir A, Friedman A. 2011. The growing role of nanotechnology in combating infectious disease. Virulence. 2:395–401.
   PubMed Web of Science ®Google Scholar
• Bochot A, Fattal E. 2012. Liposomes for intravitreal drug delivery: a state of the art. J Control Release. 161:628–634.
   PubMed Web of Science ®Google Scholar
• Borse V, Pawar V, Shetty G, Mullaji A, Srivastava R. 2016. Nanobiotechnology perspectives on prevention and treatment of ortho-paedic implant associated infection. Curr Drug Deliv. 13:175–185.
   PubMed Web of Science ®Google Scholar
• Bradfield SJ, Kumar P, White JC, Ebbs SD. 2016. Zinc, copper, or cerium accumulation from metal oxide nanoparticles or ions in sweet potato: yield effects and projected dietary intake from consumption. Plant Physiol Biochem. 110:128–137.
   PubMed Web of Science ®Google Scholar
• Briones E, Colino CI, Lanao JM. 2008. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J Control Release. 125:210–227.
   PubMed Web of Science ®Google Scholar
• Budai L, Hajdú M, Budai M, Gróf P, Béni S, Noszál B, Klebovich I, Antal I. 2007. Gels and liposomes in optimized ocular drug delivery: Studies on ciprofloxacin formulations. Int J Pharm. 343:34–40.
   PubMed Web of Science ®Google Scholar
• Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, et al. 2011. Tackling antibiotic resistance. Nat Rev Microbiol. 9:894–896.
   PubMed Web of Science ®Google Scholar
• Cabiscol E, Tamarit J, Ros J. 2000. Oxidative stress in bacteria and protein damage by reactive oxygen species. Int Microbiol. 3:3–8.
   PubMedGoogle Scholar
• Campoccia D, Montanaro L, Arciola CR. 2013. A review of the biomaterials technologies for infection-resistant surfaces. Biomaterials. 34:8533–8554.
   PubMed Web of Science ®Google Scholar
• Chakraborty SP, Sahu SK, Mahapatra SK, Santra S, Bal M, Roy S, Pramanik P. 2010. Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents. Nanotechnology. 21:105103.
   PubMed Web of Science ®Google Scholar
• Chakraborty SP, Sahu SK, Pramanik P, Roy S. 2012. In vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureus. Int J Pharm. 436:659–676.
   PubMed Web of Science ®Google Scholar
• Chang HH, Cohen T, Grad YH, Hanage WP, O'Brien TF, Lipsitch M. 2015. Origin and proliferation of multiple-drug resistance in bacterial pathogens. Microbiol Mol Biol Rev. 79:101–116.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Bandyopadhyay A, Sarkar K. 2011. Effect of iron oxide and gold nanoparticles on bacterial growth leading towards biological application. J Nanobiotechnology. 9:34.
   PubMed Web of Science ®Google Scholar
• Chen F, Liu XM, Rice KC, Li X, Yu F, Reinhardt RA, Bayles KW, Wang D. 2009. Tooth-binding micelles for dental caries prevention. Antimicrob Agents Chemother. 53:4898–4902.
   PubMed Web of Science ®Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. (1999). Bacterial biofilms: a common cause of persistent infections. Science. 284:1318–1322.
   PubMed Web of Science ®Google Scholar
• Courvalin P. 2016. Why is antibiotic resistance a deadly emerging disease? Clin Microbiol Infect. 22:405–407.
   PubMed Web of Science ®Google Scholar
• Crommelin DJA, Florence AT. 2013. Towards more effective advanced drug delivery systems. Int J Pharm. 454:496–511.
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. 2012. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 161:505–522.
   PubMed Web of Science ®Google Scholar
• Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. 1998. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 280:295–298.
   PubMed Web of Science ®Google Scholar
• de Paz LE, Resin A, Howard KA, Sutherland DS, Wejse PL. 2011. Antimicrobial effect of chitosan nanoparticles on Streptococcus mutans biofilms. Appl Environ Microbiol. 77:3892–3895.
   PubMed Web of Science ®Google Scholar
• Delcour AH. 2009. Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta. 1794:808–816.
   PubMed Web of Science ®Google Scholar
• Desjardins A, Chen T, Khalil H, Sayasith K, Lagacé J. 2002. Differential behaviour of fluid liposomes toward mammalian epithelial cells and bacteria: restriction of fusion to bacteria. J Drug Target. 10:47–54.
   PubMed Web of Science ®Google Scholar
• DiTizio V, Ferguson GW, Mittelman MW, Khoury AE, Bruce AW, DiCosmo F. 1998. A liposomal hydrogel for the prevention of bacterial adhesion to catheters. Biomaterials. 19:1877–1884.
   PubMed Web of Science ®Google Scholar
• Doi Y, Adams-Haduch JM, Peleg AY, D'Agata EMC. 2012. The role of horizontal gene transfer in the dissemination of extended-spectrum beta-lactamase–producing Escherichia coli and Klebsiella pneumoniae isolates in an endemic setting. Diagn Microbiol Infect Dis. 74:34–38.
   PubMed Web of Science ®Google Scholar
• Dornelles CM, Correa AA, Campos DS, Franco OL. 2013. Nanoformulated antibiotics: the next step for pathogenic bacteria control. Curr Med Chem. 20:1232–1240.
   PubMed Web of Science ®Google Scholar
• Drulis-Kawa Z, Dorotkiewicz-Jach A. 2010. Liposomes as delivery systems for antibiotics. Int J Pharm. 387:187–198.
   PubMed Web of Science ®Google Scholar
• Ebbs SD, Bradfield SJ, Kumar P, White JC, Musante C, Ma X. 2016. Accumulation of zinc, copper, or cerium in carrot (Daucus carota) exposed to metal oxide nanoparticles and metal ions. Environ Sci Nano. 3:114–126.
   Web of Science ®Google Scholar
• Fair RJ, Tor Y. 2014. Antibiotics and bacterial resistance in the 21st century. Perspect Medi Chem. 6:25.
   PubMedGoogle Scholar
• Falagas ME, Bliziotis IA. 2007. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents. 29:630–636.
   PubMed Web of Science ®Google Scholar
• Fernandes P. 2015. The global challenge of new classes of antibacterial agents: an industry perspective. Curr Opin Pharmacol. 24:7–11.
   PubMed Web of Science ®Google Scholar
• Fernandes MM, Ivanova K, Francesko A, Rivera D, Torrent-Burgués J, Gedanken A, Mendonza E, Tzanov T. 2016. Escherichia coli and Pseudomonas aeruginosa eradication by nano-penicillin G. Nanomedicine. 12:2061–2069.
   PubMed Web of Science ®Google Scholar
• Fleming A. 1929. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol. 10:226.
   Google Scholar
• Flemming HC, Neu TR, Wozniak DJ. 2007. The EPS matrix: the “house of biofilm cells”. J Bacteriol. 189:7945–7947.
   PubMed Web of Science ®Google Scholar
• Florence AT. 2012. “Targeting” nanoparticles: the constraints of physical laws and physical barriers. J Control Release. 164:115–24.
   PubMed Web of Science ®Google Scholar
• Forier K, Raemdonck K, De Smedt SC, Demeester J, Coenye T, Braeckmans K. 2014. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J Control Release. 190:607–623.
   PubMed Web of Science ®Google Scholar
• Fouladkhah A, Geornaras I, Sofos JN. 2013. Biofilm formation of O157 and non-O157 Shiga toxin-producing Escherichia coli and multidrug-resistant and susceptible Salmonella typhimurium and newport and their inactivation by sanitizers. J Food Sci. 78:880–886.
   Web of Science ®Google Scholar
• Gan Q, Wang T, Cochrane C, McCarron P. 2005. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces. 44:65–73.
   PubMed Web of Science ®Google Scholar
• Guo L, Yuan W, Lu Z, Li CM. 2013. Polymer/nanosilver composite coatings for antibacterial applications. Colloids Surf A. 439:69–83.
   Web of Science ®Google Scholar
• Habimana O, Le Goff C, Juillard V, Bellon-Fontaine M-N, Buist G, Kulakauskas S, Briandet R. 2007. Positive role of cell wall anchored proteinase PrtP in adhesion of lactococci. BMC Microbiol. 7:36.
   PubMed Web of Science ®Google Scholar
• Hajipour MJ, Fromm KM, Ashkarran AA, Jimenez de Aberasturi D, de Larramendi IR, Rojo T, Serpooshan V, Parak WJ, Mahmoudi M. 2012. Antibacterial properties of nanoparticles. Trends Biotechnol. 30:499–511.
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2:95–108.
   PubMed Web of Science ®Google Scholar
• Hamouda IM. 2012. Current perspectives of nanoparticles in medical and dental biomaterials. J Biomed Res. 26:143–151.
   PubMedGoogle Scholar
• Hassan MM, Ranzoni A, Phetsang W, Blaskovich MA, Cooper MA. 2016. Surface ligand density of antibiotic-nanoparticle conjugates enhances target avidity and membrane permeabilization of vancomycin-resistant bacteria. Bioconjugate Chem 28:353–361.
   PubMed Web of Science ®Google Scholar
• Hofmann AF, Eckmann L. 2006. How bile acids confer gut mucosal protection against bacteria. Proc Natl Acad Sci USA. 103:4333–4334.
   PubMed Web of Science ®Google Scholar
• Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 35:322–332.
   PubMed Web of Science ®Google Scholar
• Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJV. 2016. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 387:176–187.
   PubMed Web of Science ®Google Scholar
• Hou J, Miao L, Wang C, Wang P, Ao Y, Qian J, Dai S. 2014. Inhibitory effects of ZnO nanoparticles on aerobic wastewater biofilms from oxygen concentration profiles determined by microelectrodes. J Hazard Mater. 276:164–170.
   PubMed Web of Science ®Google Scholar
• Hu M, Zhang C, Mu Y, Shen Q, Feng Y. 2010. Indole affects biofilm formation in bacteria. Indian J Microbiol. 50:362–368.
   PubMed Web of Science ®Google Scholar
• Huang CM, Chen CH, Pornpattananangkul D, Zhang L, Chan M, Hsieh M-F, Zhang L. 2011. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials. 32:214–221.
   PubMed Web of Science ®Google Scholar
• Huh AJ, Kwon YJ. 2011. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release. 156:128–145.
   PubMed Web of Science ®Google Scholar
• Hwang G, Ahn IS, Mhin BJ, Kim JY. 2012. Adhesion of nano-sized particles to the surface of bacteria: mechanistic study with the extended DLVO theory. Colloids Surf B Biointerfaces. 97:138–144.
   PubMed Web of Science ®Google Scholar
• Hwang TJ, Carpenter D, Kesselheim AS. 2015. Paying for innovation: reimbursement incentives for antibiotics. Sci Transl Med. 7:276fs9.
   PubMed Web of Science ®Google Scholar
• Imran M, Revol-Junelles AM, Francius G, Desobry S. 2016. Diffusion of fluorescently labeled bacteriocin from edible nanomaterials and embedded nano-bioactive coatings. ACS Appl Mater Interfaces. 8:21618–21631.
   PubMed Web of Science ®Google Scholar
• Ivask A, George S, Bondarenko O, Kahru A. 2012. Metal-containing nano-antimicrobials: differentiating the impact of solubilized metals and particles. In nano-antimicrobials. Berlin Heidelberg: Springer; p. 253–290.
   Google Scholar
• Jackman JA, Yoon BK, Li D, Cho N-J. 2016b. Nanotechnology formulations for antibacterial free fatty acids and monoglycerides. Molecules. 21:305.
   PubMed Web of Science ®Google Scholar
• Jackman JA, Lee J, Cho NJ. 2016a. Nanomedicine for infectious disease applications: innovation towards broad‐spectrum treatment of viral infections. Small. 12:1133–1139.
   PubMed Web of Science ®Google Scholar
• Jamil B, Bokhari H, Imran M. 2017. Mechanism of action: how nano-antimicrobials act? Curr Drug Targets 18:363–373.
   PubMed Web of Science ®Google Scholar
• Jamil B, Habib H, Abbasi SA, Ihsan A, Nasir H, Imran M. 2016. Development of cefotaxime impregnated chitosan as nano-antibiotics: de Novo strategy to combat biofilm forming multi-drug resistant pathogens. Front Microbiol. 7:330.
   PubMed Web of Science ®Google Scholar
• Jing ZW, Jia YY, Wan N, Luo M, Huan M-L, Kang T-B, Zhou S-Y, Zhang B-L. 2016. Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori. Biomaterials. 84:276–285.
   PubMed Web of Science ®Google Scholar
• Johnson AP, Woodford N. 2013. Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol. 62:499–513.
   PubMed Web of Science ®Google Scholar
• Jung SW, Thamphiwatana S, Zhang L, Obonyo M. 2015. Mechanism of antibacterial activity of liposomal linolenic acid against Helicobacter pylori. PLoS One. 10:e0116519.
   PubMed Web of Science ®Google Scholar
• Kåhrström CT. 2013. Environmental microbiology: plant bacteria thrive in storm clouds Nat Rev Microbiol. 11:146.
   PubMed Web of Science ®Google Scholar
• Kamaruzzaman NF, Kendall S, Good L. 2016. Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections. Br J Pharmacol. [Epub ahead of print]. doi: 10.1111/bph.13664
   Google Scholar
• Kearns DB. 2010. A field guide to bacterial swarming motility. Nat Rev Microbiol. 8:634–644.
   PubMed Web of Science ®Google Scholar
• Kim JS, Kuk E, Yu KN, Kim J-H, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang C-Y, et al. 2007. Antimicrobial effects of silver nanoparticles. Nanomedicine. 3:95–101.
   PubMed Web of Science ®Google Scholar
• Koo OM, Rubinstein I, Onyuksel H. 2005. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine. 1:193–212.
   PubMed Web of Science ®Google Scholar
• Kreyling WG, Semmler-Behnke M, Chaudhry Q. 2010. A complementary definition of nanomaterial. Nano Today. 5:165–168.
   Web of Science ®Google Scholar
• Kubacka A, Diez MS, Rojo D, Bargiela R, Ciordia S, Zapico I, Albar JP, Barbas C, Martins dos Santos VAP, Fernández-García M, et al. 2014. Understanding the antimicrobial mechanism of TiO2-based nanocomposite films in a pathogenic bacterium. Sci Rep. 19:4.
   Google Scholar
• Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, et al. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 10:597–602.
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. 2010. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 75:1–18.
   PubMed Web of Science ®Google Scholar
• Kus JV, Gebremedhin A, Dang V, Tran S-L, Serbanescu A, Foster DB. 2011. Bile salts induce resistance to polymyxin in enterohemorrhagic Escherichia coliO157: H7. J Bacteriol. 193:4509–4515.
   PubMed Web of Science ®Google Scholar
• Li X, Robinson SM, Gupta A, Saha K, Jiang Z, Moyano DF, Sahar A, Riley MA, Rotello VM. 2014. Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano. 8:10682–10686.
   PubMed Web of Science ®Google Scholar
• Liu Y, Busscher HJ, Zhao B, Li Y, Zhang Z, van der Mei HC, Ren Y, Shi L. 2016. Surface-adaptive, antimicrobially loaded, micellar nanocarriers with enhanced penetration and killing efficiency in Staphylococcal biofilms. ACS Nano. 10:4779–4789.
   PubMed Web of Science ®Google Scholar
• Liu XM, Zhang Y, Chen F, Khutsishvili I, Fehringer EV, Marky LA, Bayles KW, Wang D. 2012. Prevention of orthopedic device-associated osteomyelitis using oxacillin-containing biomineral-binding liposomes. Pharm Res. 29:3169–3179.
   PubMed Web of Science ®Google Scholar
• Lutwyche P, Cordeiro C, Wiseman DJ, St-Louis M, Uh M, Hope MJ, Webb MS, Finlay BB. 1998. Intracellular delivery and antibacterial activity of gentamicin encapsulated in pH-sensitive liposomes. Antimicrob Agents Ch. 42:2511–2520.
   PubMed Web of Science ®Google Scholar
• Ma T, Shang BC, Tang H, Zhou T-H, Xu G-L, Li H-L, Chen Q-H, Xu Y-Q . 2011. Nano-hydroxyapatite/chitosan/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilms. J Biomater Sci Polym Ed. 22:1669–1681.
   PubMed Web of Science ®Google Scholar
• Madsen JS, Burmølle M, Hansen LH, Sørensen SJ. 2012. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol Med Microbiol. 65:183–195.
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 18:268–281.
   PubMed Web of Science ®Google Scholar
• Mahon E, Salvati A, Baldelli Bombelli F, Lynch I, Dawson KA . 2012. Designing the nanoparticle-biomolecule interface for “targeting and therapeutic delivery”. J Control Release. 161:164–174.
   PubMed Web of Science ®Google Scholar
• Mandal B, Bhattacharjee H, Mittal N, Sah H, Balabathula P, Thoma LA, Wood GC. 2013. Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform. Nanomed Nanotechnol. 9:474–491.
   PubMed Web of Science ®Google Scholar
• Manke A, Wang L, Rojanasakul Y. 2013. Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed Res Int. 94:2916.
   Google Scholar
• Marquez B. 2005. Bacterial efflux systems and efflux pumps inhibitors. Biochimie. 87:1137–1147.
   PubMed Web of Science ®Google Scholar
• Maurin M, Raoult D. 2001. Use of aminoglycosides in treatment of infections due to intracellular bacteria. Antimicrob Agents Chemother. 45:2977–2986.
   PubMed Web of Science ®Google Scholar
• Meers P, Neville M, Malinin V, Scotto AW, Sardaryan G, Kurumunda R, Mackinson C, James G, Fisher S, Perkins WR, et al. 2008. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J Antimicrob Chemother. 61:859–868.
   PubMed Web of Science ®Google Scholar
• Merchant Z, Buckton G, Taylor KMG, Stapleton P, Saleem IY, Zariwala MG, Somavarapu S. 2016. A new era of pulmonary delivery of nano-antimicrobial therapeutics to treat chronic pulmonary infections. Curr Pharm Des. 22:2577–2598.
   PubMed Web of Science ®Google Scholar
• Michael RW, Brown PJC, Peter G. 1990. Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrob Agents Chemother. 34:1623–1628.
   PubMed Web of Science ®Google Scholar
• Montagu A, Joly-Guillou ML, Guillet C, Bejaud J, Rossines E, Saulnier P. 2016. Demonstration of the interactions between aromatic compound-loaded lipid nanocapsules and Acinetobacter baumannii bacterial membrane. Int J Pharm. 506:280–288.
   PubMedGoogle Scholar
• Mugabe C, Azghani AO, Omri A. 2005. Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother. 55:269–271.
   PubMed Web of Science ®Google Scholar
• Muppidi K, Wang J, Betageri G, Pumerantz AS. 2011. PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin. Antimicrob Agents Chemother. 55:4537–4542.
   PubMed Web of Science ®Google Scholar
• Mura S, Nicolas J, Couvreur P. 2013. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 12:991–1003.
   PubMed Web of Science ®Google Scholar
• Nacucchio MC, Bellora MJ, Sordelli DO, D'Aquino M. 1985. Enhanced liposome-mediated activity of piperacillin against staphylococci. Antimicrob Agents Chemother. 27:137–139.
   PubMed Web of Science ®Google Scholar
• Obonyo M, Zhang L, Thamphiwatana S, Pornpattananangkul D, Fu V, Zhang L. 2012. Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori. Mol Pharm. 9:2677–2685.
   PubMed Web of Science ®Google Scholar
• Oh YK, Nix DE, Straubinger RM. 1995. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. Antimicrob Agents Ch. 39:2104–2111.
   PubMed Web of Science ®Google Scholar
• Parveen S, Misra R, Sahoo SK. 2012. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine. 8:147–166.
   PubMed Web of Science ®Google Scholar
• Pelgrift RY, Friedman AJ. 2013. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 65:1803–1815.
   PubMed Web of Science ®Google Scholar
• Perez F, Endimiani A, Hujer KM, Bonomo RA. 2007. The continuing challenge of ESBLs. Curr Opin Pharmacol. 7:459–469.
   PubMed Web of Science ®Google Scholar
• Piddock LJ. 2016. Assess drug-resistance phenotypes, not just genotypes. Nat Microbiol. 1:16120.
   PubMed Web of Science ®Google Scholar
• Pornpattananangkul D, Fu V, Thamphiwatana S, Zhang L, Chen M, Vecchio J, Gao W, Huang C-M, Zhang L. 2013. In vivo treatment of Propionibacterium acnes infection with liposomal lauric acids. Adv HealthC Mater. 2:1322–1328.
   PubMed Web of Science ®Google Scholar
• Poulikakos P, Tansarli GS, Falagas ME. 2014. Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review. Eur J Clin Microbiol Infect Dis. 33:1675–1685.
   PubMed Web of Science ®Google Scholar
• Pumerantz K, Muppidi S, Agnihotri C, Guerra C, Venketaraman V, Wang J, Betageri G. 2011. Preparation of liposomal vancomycin and intracellular killing of methicillin resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents. 37:140–144.
   PubMed Web of Science ®Google Scholar
• Qayyum S, Khan AU. 2016. Nanoparticles vs. biofilms: a battle against another paradigm of antibiotic resistance. Med Chem Comm. 7:1479–1498.
   Web of Science ®Google Scholar
• Rabea EI, Badawy MET, Stevens CV, Smagghe G, Steurbaut W. 2003. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules. 4:1457–1465.
   PubMed Web of Science ®Google Scholar
• Radzig MA, Nadtochenko VA, Koksharova OA, Kiwi J, Lipasova VA, Khmel IA. 2013. Antibacterial effects of silver nanoparticles on gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of action. Colloids Surf B Biointerfaces. 102:300–306.
   PubMed Web of Science ®Google Scholar
• Roy CR, Kagan JC. 2000. Evasion of phagosome lysosome fusion and establishment of a replicative organelle by the intracellular pathogen Legionella pneumophila. In: Madame Curie Bioscience Database [Internet]. Austin (TX): Landes Bioscience; 2000–2013. Available from: https://www.ncbi.nlm.nih.gov/books/NBK6111/
   Google Scholar
• Sachetelli S, Khalil H, Chen T, Beaulac C, Sénéchal S, Lagacé J. 2000. Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells. Biochim Biophys Acta. 1463:254–266.
   PubMed Web of Science ®Google Scholar
• Safari J, Zarnegar Z. 2014. Advanced drug delivery systems: nanotechnology of health design: a review. J Saudi Chem Soc. 18:85–99.
   Web of Science ®Google Scholar
• Salmaso S, Caliceti P. 2013. Stealth properties to improve therapeutic efficacy of drug nanocarriers. J Drug Deliv. 2013:374252.
   PubMedGoogle Scholar
• Sana TG, Monack DM. 2016. Microbiology: the dark side of antibiotics. Nature. 534:624–625.
   PubMed Web of Science ®Google Scholar
• Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. 2007. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine. 3:168–171.
   PubMed Web of Science ®Google Scholar
• Shamaila S, Zafar N, Riaz S, Sharif R, Nazir J, Naseem S. 2016. Gold nanoparticles: an efficient antimicrobial agent against enteric bacterial human pathogen. Nanomaterials. 6:71.
   Web of Science ®Google Scholar
• Shen Z, Nieh MP, Li Y. 2016. Decorating nanoparticle surface for targeted drug delivery: opportunities and challenges. Polymers. 8:83.
   PubMed Web of Science ®Google Scholar
• Sheng Z, Liu Y. 2011. Effects of silver nanoparticles on wastewater biofilms. Water Res. 45:6039–6050.
   PubMed Web of Science ®Google Scholar
• Silhavy TJ, Kahne D, Walker S. 2010. The bacterial cell envelope. Cold Spring Harb Perspect Biol. 2:a000414.
   PubMed Web of Science ®Google Scholar
• Singh R, Smitha MS, Singh SP. 2014. The role of nanotechnology in combating multi-drug resistant bacteria. J Nanosci Nanotechnol. 14:4745–4756.
   PubMed Web of Science ®Google Scholar
• Singla R, Guliani A, Kumari A, Yadav SK. 2016. Metallic nanoparticles, toxicity issues and applications in medicine. In: Nanoscale materials in targeted drug delivery, theragnosis and tissue regeneration. Singapore: Springer; p. 41–80.
   Google Scholar
• Smith AW. 2005. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev. 57:1539–1550.
   PubMed Web of Science ®Google Scholar
• Sosnik A, Carcaboso AM, Glisoni RJ, Moretton MA, Chiappetta DA. 2010. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery. Adv Drug Deliv Rev. 62:547–559.
   PubMed Web of Science ®Google Scholar
• Stewart PS. 2002. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol. 292:107–113.
   PubMed Web of Science ®Google Scholar
• Stewart PS. 2003. Diffusion in biofilms. J Bacteriol. 185:1485–1491.
   PubMed Web of Science ®Google Scholar
• Suri SS, Fenniri H, Singh B. 2007. Nanotechnology-based drug delivery systems. J Occup Med Toxicol. 2:16.
   PubMedGoogle Scholar
• Tariq M, Mohurle S, Patravale VB, Aruna K. 2016. Formulation of β-lactam antibiotic encapsulated micro- and multiple-emulsions, and evaluation of its antibacterial activity against β-lactamase producing uropathogens. Int J Curr Microbiol App Sci. 5:190–201.
   Google Scholar
• Thamphiwatana S, Gao W, Obonyo M, Zhang L. 2014. In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation. Proc Natl Acad Sci USA. 111:17600–17605.
   PubMed Web of Science ®Google Scholar
• Thorley AJ, Tetley TD. 2013. New perspectives in nanomedicine. Pharmacol Therapeut. 140:176–185.
   PubMed Web of Science ®Google Scholar
• Usman MS. 2013. Synthesis, characterization, and antimicrobial properties of copper nanoparticles. Int J Nanomedicine. 8:4467–4479.
   PubMed Web of Science ®Google Scholar
• Wang D, Lin Z, Wang T, Yao Z, Qin M, Zheng S, Lu W. 2016. Where does the toxicity of metal oxide nanoparticles come from: the nanoparticles, the ions, or a combination of both? J Hazard Mater. 308:328–334.
   PubMed Web of Science ®Google Scholar
• Watnick P, Kolter R. 2000. Biofilm, city of microbes. J Bacteriol. 182:2675–2679.
   PubMed Web of Science ®Google Scholar
• Wood TK, Knabel SJ, Kwan BW. 2012. Bacterial persister cell formation and dormancy. Appl Environ Microbiol. 79:7116–7121.
   Web of Science ®Google Scholar
• Wright GD, Sutherland AD. 2007. New strategies for combating multidrug-resistant bacteria. Trends Mol Med. 13:260–267.
   PubMed Web of Science ®Google Scholar
• Xie Y, He Y, Irwin PL, Jin T, Shi X. 2011. Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni. Appl Environ Microbiol. 77:2325–2331.
   PubMed Web of Science ®Google Scholar
• Xie S, Tao Y, Pan Y, Qu W, Cheng G, Huang L, Chen D, Wang X, Liu Z, Yuan Z. 2014. Biodegradable nanoparticles for intracellular delivery of antimicrobial agents. J Control Release. 187:101–117.
   PubMed Web of Science ®Google Scholar
• Xiong MH, Bao Y, Yang XZ, Zhu Y-H, Wang J. 2014. Delivery of antibiotics with polymeric particles. Adv Drug Deliv Rev. 78:63–76.
   PubMed Web of Science ®Google Scholar
• Yamakami K, Tsumori H, Sakurai Y, Shimizu Y, Nagatoshi K, Sonomoto K. 2013. Sustainable inhibition efficacy of liposome-encapsulated nisin on insoluble glucan-biofilm synthesis by Streptococcus mutans. Pharm Biol. 51:267–270.
   PubMed Web of Science ®Google Scholar
• Yang CC, Mai YW. 2014. Thermodynamics at the nanoscale: a new approach to the investigation of unique physicochemical properties of nanomaterials. Mat Sci Eng R. 79:1–40.
   Web of Science ®Google Scholar
• Yang D, Pornpattananangkul D, Nakatsuji T, Chan M, Carson D, Huang C-M, Zhang L. 2009. The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes. Biomaterials. 30:6035–6040.
   PubMed Web of Science ®Google Scholar
• Yildirimer L, Thanh NTK, Loizidou M, Seifalian AM. 2011. Toxicology and clinical potential of nanoparticles. Nano Today. 6:585–607.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chan HF, Leong KW. 2013. Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev. 65:104–120.
   PubMed Web of Science ®Google Scholar